Glycogen storage disease type I and G6Pase-β deficiency: Etiology and therapy

Nature Reviews Endocrinology

Volumn 6, Issue 12, 2010, Pages 676-688

  Chou, Janice Y ^a   Jun, Hyun Sik ^a   Mansfield, Brian C ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ANTILIPEMIC AGENT; CARRIER PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE 6 PHOSPHATASE; GLUCOSE 6 PHOSPHATASE ALPHA; GLUCOSE 6 PHOSPHATASE BETA; GLUCOSE 6 PHOSPHATE; GLUCOSE 6 PHOSPHATE TRANSPORTER; GRANULOCYTE COLONY STIMULATING FACTOR; MESALAZINE; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; DIET THERAPY; ENTEROCOLITIS; ENZYME INACTIVATION; GENE MUTATION; GENE THERAPY; GLUCOSE 6 PHOSPHATASE BETA DEFICIENCY; GLUCOSE HOMEOSTASIS; GLYCOGEN STORAGE DISEASE TYPE 1; GLYCOGEN STORAGE DISEASE TYPE 1A; GLYCOGEN STORAGE DISEASE TYPE 1B; HUMAN; HYPERLIPIDEMIA; KIDNEY DYSFUNCTION; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MYELODYSPLASTIC SYNDROME; NEUTROPENIA; NONHUMAN; PRIORITY JOURNAL; REVIEW; SPLENOMEGALY;

ANIMALS; GENE THERAPY; GENOTYPE; GLUCOSE-6-PHOSPHATASE; GLYCOGEN STORAGE DISEASE TYPE I; HUMANS; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MODELS, BIOLOGICAL; PHENOTYPE;

EID: 78649449365     PISSN: 17595029     EISSN: 17595037     Source Type: Journal    
DOI: 10.1038/nrendo.2010.189     Document Type: Review

References (122)

1. Chou, J. Y., Matern, D., Mansfield, B. C. & Chen, Y. T. Type I glycogen storage diseases: disorders of the glucose-6-phosphatase complex. Curr. Mol. Med. 2, 121-143 (2002).
2. Chou, J. Y. & Mansfield, B. C. in Membrane Transporter Diseases, Ch. 13 (eds Broer, S. & Wagner, C. A.) 191-205 (Springer, New York, 2003).
3. Lei, K.-J., Shelly, L. L., Pan, C.-J., Sidbury, J. B. & Chou, J. Y. Mutations in the glucose-6-phosphatase gene that cause glycogen storage disease type 1a. Science 262, 580-583 (1993).
4. Lei, K.-J., Pan, C.-J., Shelly, L. L., Liu, J.-L. & Chou, J. Y. Identification of mutations in the gene for glucose-6-phosphatase, the enzyme deficient in glycogen storage disease type 1a. J. Clin. Invest. 93, 1994-1999 (1994).
5. Hiraiwa, H., Pan, C.-J., Lin, B., Moses, S. W. & Chou, J. Y. Inactivation of the glucose 6-phosphate transporter causes glycogen storage disease type 1b. J. Biol. Chem. 274, 5532-5536 (1999).
6. Gerin, I., Veiga-da-Cunha, M., Achouri, Y., Collet, J.-F. & Van Schaftingen, E. Sequence of a putative glucose 6-phosphate translocase, mutated in glycogen storage disease type Ib. FEBS Lett 419, 235-238 (1997).
7. Annabi, B. et al. The gene for glycogen-storage disease type 1b maps to chromosome 11q23. Am. J. Hum. Genet. 62, 400-405 (1998).
8. Gerin, I., Veiga-da-Cunha, M., Noël, G. & Van Schaftingen, E. Structure of the gene mutated in glycogen storage disease type Ib. Gene 227, 189-195 (1999).
9. Veiga-da-Cunha, M. et al. A gene on chromosome 11q23 coding for a putative glucose-6-phosphate translocase is mutated in glycogenstorage disease types Ib and Ic. Am. J. Hum. Genet 63, 976-983 (1998).
10. Veiga-da-Cunha, M. et al. The putative glucose 6-phosphate translocase gene is mutated in essentially all cases of glycogen storage disease type I non-a. Eur. J. Hum. Genet. 7, 717-723 (1999).
11. Galli, L. et al. Mutations in the glucose-6-phosphate transporter (G6PT) gene in patients with glycogen storage diseases type 1b and 1c. FEBS Lett 459, 255-258 (1999).
12. Janecke, A. R. et al. Mutation analysis in glycogen storage disease type 1 non-a. Hum. Genet 107, 285-289 (2000).
13. Chen, S. Y. et al. The glucose-6-phosphate transporter is a phosphate-linked antiporter deficient in glycogen storage disease type Ib and Ic. FASEB J. 22, 2206-2213 (2008).
14. Pan, C.-J., Lei, K.-J., Chen, H., Ward, J. M. & Chou, J. Y. Ontogeny of the murine glucose-6-phosphatase system. Arch. Biochem. Biophys. 358, 17-24 (1998).
15. Lin, B., Annabi, B., Hiraiwa, H., Pan, C.-J. & Chou, J. Y. Cloning and characterization of cDNAs encoding a candidate glycogen storage disease type 1b protein in rodents. J. Biol. Chem. 273, 31656-31660 (1998).
16. Shieh, J.-J., Pan, C.-J., Mansfield, B. C. & Chou, J. Y. A glucose-6-phosphate hydrolase, widely expressed outside the liver, can explain age-dependent resolution of hypoglycemia in glycogen storage disease type Ia. J. Biol. Chem. 278, 47098-47103 (2003).
17. Guionie, O., Clottes, E., Stafford, K. & Burchell, A. Identification and characterisation of a new human glucose-6-phosphatase isoform. FEBS Lett 551, 159-164 (2003).
18. Ghosh, A., Shieh, J.-J., Pan, C.-J. & Chou, J. Y Histidine-167 is the phosphate acceptor in glucose-6-phosphatase-β forming a phosphohistidine-enzyme intermediate during catalysis. J. Biol. Chem. 279, 12479-12483 (2004).
19. Cheung, Y. Y. et al. Impaired neutrophil activity and increased susceptibility to bacterial infection in mice lacking glucose-6-phosphatase- β. J. Clin. Invest. 117, 784-793 (2007).
20. Kim, S. Y., Jun, H. S., Mead, P. A., Mansfield, B. C. & Chou, J. Y. Neutrophil stress and apoptosis underlie myeloid dysfunction in glycogen storage disease type Ib. Blood 111, 5704-5711 (2008).
21. Boztug, K. et al. A syndrome with congenital neutropenia and mutations in G6PC3. N. Engl. J. Med. 360, 32-43 (2009).
22. Pan, C.-J., Lei, K.-J., Annabi, B. & Chou, J. Y. Transmembrane topology of glucose-6-phosphatase. J. Biol. Chem. 273, 6144-6148 (1998).
23. 176 is the nucleophile forming the phosphohistidine-enzyme intermediate during catalysis. J. Biol. Chem. 277, 32837-32842 (2002).
24. Chou, J. Y. & Mansfield, B. C. Mutations in the glucose-6- phosphatase-α (G6PC) gene that cause type Ia glycogen storage disease. Hum. Mutat. 29, 921-930 (2008).
25. Lei, K.-J. et al. Genetic basis of glycogen storage disease type 1a: prevalent mutations at the glucose-6-phosphatase locus. Am. J. Hum. Genet. 57, 766-771 (1995).
26. Bruni, N. et al. Enzymatic characterization of four new mutations in the glucose-6 phosphatase (G6PC) gene which cause glycogen storage disease type 1a. Ann. Hum. Genet. 63, 141-146 (1999).
27. Takahashi, K. et al. Heterogeneous mutations in the glucose-6-phosphatase gene in Japanese patients with glycogen storage disease type Ia. Am. J. Med. Genet. 92, 90-94 (2000).
28. Shieh, J.-J. et al. The molecular basis of glycogen storage disease type 1a: structure and function analysis of mutations in glucose-6-phosphatase. J. Biol. Chem. 277, 5047-5053 (2002).
29. Angaroni, C. J. et al. Glycogen storage disease type Ia in Argentina: two novel glucose-6-phosphatase mutations affecting protein stability. Mol. Genet. Metab. 83, 276-279 (2004).
30. Keller, K. M. et al. A new mutation of the glucose-6-phosphatase gene in a 4-year-old girl with oligosymptomatic glycogen storage disease type 1a. J. Pediatr. 132, 360-361 (1998).
31. Rake, J. P. et al. Identification of a novel mutation (867delA) in the glucose-6-phosphatase gene in two siblings with glycogen storage disease type Ia with different phenotypes. Hum. Mutat. 15, 381 (2000).
32. Matern D., Seydewitz, H. H., Bali, D., Lang, C. & Chen, Y. T. Glycogen storage disease type I: diagnosis and phenotype/genotype correlation. Eur. J. Pediatr. 161 (Suppl. 1), S10-S19 (2002).
33. Nakamura, T., Ozawa, T., Kawasaki, T., Nakamura, H. & Sugimura, H. Glucose-6-phosphatase gene mutations in 20 adult Japanese patients with glycogen storage disease type 1a with reference to hepatic tumors. J. Gastroenterol. Hepatol. 16, 1402-1408 (2001).
34. Akanuma, J. et al. Glycogen storage disease type Ia: molecular diagnosis of 51 Japanese patients and characterization of splicing mutations by analysis of ectopically transcribed mRNA from lymphoblastoid cells. Am. J. Med. Genet. 91, 107-112 (2000).
35. Weston, B. W. et al. Glucose-6-phosphatase mutation G188R confers an atypical glycogen storage disease type 1b phenotype. Pediatr. Res. 48, 329-334 (2000).
36. Pan, C.-J., Lin, B. & Chou, J. Y. Transmembrane topology of human glucose 6-phosphate transporter. J. Biol. Chem. 274, 13865-13869 (1999).
37. Chou, J. Y., Jun, H. S. & Mansfield, B. C. Neutropenia in type Ib glycogen storage disease. Curr. Opin. Hematol. 17, 36-42 (2010).
38. Chen, L.-Y., Lin, B., Pan, C.-J., Hiraiwa, H. & Chou, J. Y. Structural requirements for the stability and microsomal transport activity of the human glucose 6-phosphate transporter. J. Biol. Chem. 275, 34280-34286 (2000).
39. Chen, L.-Y., Pan, C.-J., Shieh, J.-J. & Chou, J. Y. Structure-function analysis of the glucose-6-phosphate transporter deficient in glycogen storage disease type Ib. Hum. Mol. Genet. 11, 3199-3207 (2002).
40. Chen, S.-Y., Pan, C.-J., Lee, S., Peng, W. & Chou, J. Y. Functional analysis of mutations in the glucose-6-phosphate transporter that cause glycogen storage disease type Ib. Mol. Genet. Metab. 95, 220-223 (2008).
41. Melis, D. et al. Genotype/phenotype correlation in glycogen storage disease type 1b: a multicentre study and review of the literature. Eur. J. Pediatr. 164, 501-508 (2005). (Pubitemid 41073817)
42. Kure, S. et al. Glycogen storage disease type Ib without neutropenia. J. Pediatr. 137, 253-256 (2000).
43. Martens, D. H. et al. A patient with common glycogen storage disease type Ib mutations without neutropenia or neutrophil dysfunction. J. Inherit. Metab. Dis. 29, 224-225 (2006).
44. Angaroni, C. J. et al. Glycogen storage disease type Ib without neutropenia generated by a novel splice-site mutation in the glucose-6-phosphate translocase gene. Mol. Genet. Metab. 88, 96-99 (2006).
45. Martin, C. C. et al. Identification and characterization of a human cDNA and gene encoding a ubiquitously expressed glucose-6-phosphatase catalytic subunit-related protein. J. Mol. Endocrinol. 29, 205-222 (2002).
46. Aróstegui, J. I. et al. A novel G6PC3 homozygous 1-bp deletion as a cause of severe congenital neutropenia. Blood 114, 1718-1719 (2009).
47. Xia, J. et al. Prevalence of mutations in ELANE, GFI1, HAX1, SBDS, WAS and G6PC3 in patients with severe congenital neutropenia. Br. J. Haematol. 147, 535-542 (2009).
48. Banugaria, S. G., Austin, S. L., Boney, A., Weber, T. J. & Kishnani, P. S. Hypovitaminosis D in glycogen storage disease type I. Mol. Genet. Metab. 99, 434-437 (2010).
49. Bandsma, R. H. et al. Increased de novo lipogenesis and delayed conversion of large vLDL into intermediate density lipoprotein particles contribute to hyperlipidemia in glycogen storage disease type 1a. Pediatr. Res. 63, 702-707 (2008).
50. Melis, D. et al. The growth hormone-insulin-like growth factor axis in glycogen storage disease type 1: evidence of different growth patterns and insulin-like growth factor levels in patients with glycogen storage disease type 1a and 1b. J. Pediatr. 156, 663-670 (2010).
51. Kilpatrick, L. et al. Impaired metabolic function and signaling defects in phagocytic cells in glycogen storage disease type 1b. J. Clin. Invest. 86, 196-202 (1990).
52. Gitzelmann, R. & Bosshard, N. U. Defective neutrophil and monocyte functions in glycogen storage disease type Ib: a literature review. Eur. J. Pediatr. 152 (Suppl. 1), S33-S38 (1993).
53. Visser, G. et al. Neutropenia, neutrophil dysfunction, and inflammatory bowel disease in glycogen storage disease type Ib: results of the European Study on Glycogen Storage Disease type I. J. Pediatr. 137, 187-191 (2000).
54. Dieckgraefe, B. K., Korzenik, J. R., Husain, A. & Dieruf, L. Association of glycogen storage disease 1b and Crohn disease: results of a North American survey. Eur. J. Pediatr. 161 (Suppl. 1), S88-S92 (2002).
55. Melis, D. et al. Increased prevalence of thyroid autoimmunity and hypothyroidism in patients with glycogen storage disease type I. J. Pediatr. 150, 300-305 (2007).
56. Kuijpers, T. W. et al. Apoptotic neutrophils in the circulation of patients with glycogen storage disease type 1b (GSD1b). Blood 101, 5021-5024 (2003).
57. Chen, L.-Y. et al. Impaired glucose homeostasis, neutrophil trafficking and function in mice lacking the glucose-6-phosphate transporter. Hum. Mol. Genet. 12, 2547-2558 (2003).
58. Stjernholm, R. L., Burns, C. P. & Hohnadel, J. H. Carbohydrate metabolism by leukocytes. Enzyme 13, 7-31 (1972).
59. Bashan, N., Potashnik, R., Hagay, Y. & Moses, S. W. Impaired glucose transport in polymorphonuclear leukocytes in glycogen storage disease Ib. J. Inherit. Metab. Dis. 10, 234-241 (1987).
60. Verhoeven, A. J. et al. A convenient diagnostic function test of peripheral blood neutrophils in glycogen storage disease type Ib. Pediatr. Res. 45, 881-885 (1999).
61. Medina, R. A., Southworth, R., Fuller, W. & Garlick, P. B. Lactate-induced translocation of GLUT1 and GLUT4 is not mediated by the phosphatidyl-inositol-3-kinase pathway in the rat heart. Basic Res. Cardiol. 97, 168-176 (2002).
62. 12 skeletal muscle cells. Arch. Biochem. Biophys. 401, 205-214 (2002).
63. Rake, J. P. et al. Glycogen storage disease type I: diagnosis, management, clinical course and outcome. Results of the European Study on Glycogen Storage Disease Type I (ESGSD I). Eur. J. Pediatr. 161 (Suppl. 1), S20-S34 (2002).
64. Chou, J. Y., Mansfield, B. C. & Weinstein, D. A. in Genetic Diseases of the Kidney Ch. 41 (eds Lifton, R. P. et al.) 693-708 (Academic Press, New York, 2009).
65. Weinstein, D. A., Somers, M. J. & Wolfsdorf, J. I. Decreased urinary citrate excretion in type 1a glycogen storage disease. J. Pediatr. 138, 378-382 (2001).
66. Chen, Y. T., Coleman, R. A., Scheinman, J. I., Kolbeck, P. C. & Sidbury, J. B. Renal disease in type I glycogen storage disease. N. Engl. J. Med. 318, 7-11 (1988).
67. Verani, R. & Bernstein, J. Renal glomerular and tubular abnormalities in glycogen storage disease type I. Arch. Pathol. Lab. Med. 112, 271-274 (1988). (Pubitemid 18076309)
68. Baker, L. et al. Hyperfiltration and renal disease in glycogen storage disease, type I. Kidney Int. 35, 1345-1350 (1989).
69. Urushihara, M. et al. Transforming growth factorbeta in renal disease with glycogen storage disease I. Pediatr. Nephrol. 19, 676-678 (2004).
70. Yiu, W. H. et al. Angiotensin mediates renal fibrosis in the nephropathy of glycogen storage disease type Ia. Kidney Int. 73, 716-723 (2008).
71. Yiu, W. H., Mead, P. A., Jun, H. S., Mansfield, B. C. & Chou, J. Y. Oxidative stress mediates nephropathy in type Ia glycogen storage disease. Lab. Invest. 90, 620-629 (2010).
72. Bianchi, L. Glycogen storage disease I and hepatocellular tumours. Eur. J. Pediatr. 52 (Suppl. 1), S63-S70 (1993).
73. Labrune, P., Trioche, P., Duvaltier, I., Chevalier, P. & Odièvre, M. Hepatocellular adenomas in glycogen storage disease type I and III: a series of 43 patients and review of the literature. J. Pediatr. Gastroenterol. Nutr. 24, 276-279 (1997).
74. Lee, P. J. Glycogen storage disease type I: pathophysiology of liver adenomas. Eur. J. Pediatr. 161 (Suppl. 1), S46-S49 (2002).
75. Weinstein, D. A. et al. Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease. Blood 100, 3776-3781 (2002).
76. Franco, L. M. et al. Hepatocellular carcinoma in glycogen storage disease type Ia: a case series. J. Inherit. Metab. Dis. 28, 153-162 (2005).
77. Di Rocco, M. et al. Hepatocellular adenoma and metabolic balance in patients with type Ia glycogen storage disease. Mol. Genet. Metab. 93, 398-402 (2008).
78. Kim, S. Y., Weinstein, D. A., Starost, M. F., Mansfield, B. C. & Chou, J. Y. Necrotic foci, elevated chemokines and infiltrating neutrophils in the liver of glycogen storage disease type Ia. J. Hepatol. 48, 479-485 (2008).
79. Sun, B. et al. Activation of glycolysis and apoptosis in glycogen storage disease type Ia. Mol. Genet. Metab. 97, 267-271 (2009).
80. Zucman-Rossi, J. et al. Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology 43, 515-524 (2006).
81. Bioulac-Sage, P. et al. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology 46, 740-748 (2007).
82. Kishnani, P. S. et al. Chromosomal and genetic alterations in human hepatocellular adenomas associated with type Ia glycogen storage disease. Hum. Mol. Genet. 18, 4781-4790 (2009).
83. Lei, K.-J. et al. Glucose-6-phosphatase dependent substrate transport in the glycogen storage disease type-1a mouse. Nat. Genet. 13, 203-209 (1996).
84. Kishnani, P. S. et al. Canine model and genomic structural organization of glycogen storage disease type Ia (GSD Ia). Vet. Pathol. 38, 83-91 (2001).
85. Rake, J. P. et al. Glycogen storage disease type Ia: recent experience with mutation analysis, a summary of mutations reported in the literature and a newly developed diagnostic flowchart. Eur. J. Pediatr. 159, 322-330 (2000).
86. Greene, H. L., Slonim, A. E., O'Neill, J. A. Jr & Burr, I. M. Continuous nocturnal intragastric feeding for management of type 1 glycogenstorage disease. N. Engl. J. Med. 294, 423-425 (1976).
87. Chen, Y. T., Cornblath, M. & Sidbury, J. B. Cornstarch therapy in type I glycogen-storage disease. N. Engl. J. Med. 310, 171-175 (1984).
88. Koeberl, D. D., Kishnani, P. S., Bali, D. & Chen, Y. T. Emerging therapies for glycogen storage disease type I. Trends Endocrinol. Metab. 20, 252-258 (2009).
89. Weinstein, D. A. & Wolfsdorf, J. I. Effect of continuous glucose therapy with uncooked cornstarch on the long-term clinical course of type 1a glycogen storage disease. Eur. J. Pediatr. 161 (Suppl. 1), S35-S39 (2002).
90. Correia, C. E. et al. Use of modified cornstarch therapy to extend fasting in glycogen storage disease types Ia and Ib. Am. J. Clin. Nutr. 88, 1272-1276 (2008).
91. Nagasaka, H. et al. Improvements of hypertriglyceridemia and hyperlacticemia in Japanese children with glycogen storage disease type Ia by medium-chain triglyceride milk. Eur. J. Pediatr. 166, 1009-1016 (2007).
92. Melis, D. et al. Efficacy of ACE-inhibitor therapy on renal disease in glycogen storage disease type 1: a multicentre retrospective study. Clin. Endocrinol. (Oxf.) 63, 19-25 (2005). (Pubitemid 40966397)
93. Martens, D. H. et al. Renal function in glycogen storage disease type I, natural course, and renopreservative effects of ACE inhibition. Clin. J. Am. Soc. Nephrol. 4, 1741-1746 (2009).
94. Visser, G. et al. Granulocyte colony-stimulating factor in glycogen storage disease type 1b. Results of the European Study on Glycogen Storage Disease Type 1. Eur. J. Pediatr. 161 (Suppl. 1), S83-S87 (2002).
95. Calderwood, S. et al. Recombinant human granulocyte colony-stimulating factor therapy for patients with neutropenia and/or neutrophil dysfunction secondary to glycogen storage disease type 1b. Blood 97, 376-382 (2001).
96. Visser, G. et al. Consensus guidelines for management of glycogen storage disease type 1b-European Study on Glycogen Storage Disease Type 1. Eur. J. Pediatr. 161 (Suppl. 1), S120-S123 (2002).
97. Davis, M. K., Rufo, P. A., Polyak, S. F. & Weinstein, D. A. Adalimumab for the treatment of Crohn-like colitis and enteritis in glycogen storage disease type Ib. J. Inherit. Metab. Dis. doi:10.1007/s10545-077-0774-9.
98. Donadieu, J. et al. Analysis of risk factors for myelodysplasias, leukemias and death from infection among patients with congenital neutropenia. Experience of the French Severe Chronic Neutropenia Study Group. Haematologica 90, 45-53 (2005).
99. Simmons, P. S., Smithson, W. A., Gronert, G. A. & Haymond, M. W. Acute myelogenous leukemia and malignant hyperthermia in a patient with type 1b glycogen storage disease. J. Pediatr. 105, 428-431 (1984).
100. Pinsk, M. et al. Acute myelogenous leukemia and glycogen storage disease 1b. J. Pediatr. Hematol. Oncol. 24, 756-758 (2002).
101. Schroeder, T., Hildebrandt, B., Mayatepek, E., Germing, U. & Haas, R. A patient with glycogen storage disease type Ib presenting with acute myeloid leukemia (AML) bearing monosomy 7 and translocation t (3;8) (q26;q24) after 14 years of treatment with granulocyte colony-stimulating factor (G-CSF): a case report. J. Med. Case Reports 2, 319 (2008).
102. Faivre, L. et al. Long-term outcome of liver transplantation in patients with glycogen storage disease type Ia. J. Inherit. Metab. Dis. 22, 723-732 (1999).
103. Matern, D. et al. Liver transplantation for glycogen storage disease types, I, III, and I V. Eur. J. Pediatr. 158 (Suppl. 2), S43-S48 (1999).
104. Davis, M. K. & Weinstein, D. A. Liver transplantation in children with glycogen storage disease: controversies and evaluation of the risk/benefit of this procedure. Pediatr. Transplant. 12, 137-145 (2008).
105. Reddy, S. K. et al. Liver transplantation for glycogen storage disease type Ia. J. Hepatol. 51, 483-490 (2009).
106. Labrune, P. Glycogen storage disease type I: indications for liver and/or kidney transplantation. Eur. J. Pediatr. 161 (Suppl. 1), S53-S55 (2002).
107. Reddy, S. K. et al. Resection of hepatocellular adenoma in patients with glycogen storage disease type Ia. J. Hepatol. 47, 658-663 (2007).
108. Iyer, S. G. et al. Long-term results of living donor liver transplantation for glycogen storage disorders in children. Liver Transpl. 13, 848-852 (2007).
109. Kasahara, M. et al. Living donor liver transplantation for glycogen storage disease type Ib. Liver Transpl. 15, 1867-1871 (2009).
110. Ji, H. F. et al. Reduced-size liver transplantation for glycogen storage disease. Hepatobiliary Pancreat. Dis. Int. 8, 106-108 (2009).
111. Kim, S. Y. et al. Bone-marrow derived cells require a functional glucose-6-phosphate transporter for normal myeloid functions. J. Biol. Chem. 281, 28794-28801 (2006).
112. Pierre, G. et al. A. Bone marrow transplantation in glycogen storage disease type 1b. J. Pediatr. 152, 286-288 (2008).
113. Zingone, A. et al. Correction of glycogen storage disease type 1a in a mouse model by gene therapy. J. Biol. Chem. 275, 828-832 (2000).
114. Koeberl, D. D. et al. Efficacy of helper-dependent adenovirus vector-mediated gene therapy in murine glycogen storage disease type Ia. Mol. Ther. 15, 1253-1258 (2007).
115. Ghosh, A. et al. Long-term correction of murine glycogen storage disease type Ia by recombinant adeno-associated virus-1-mediated gene transfer. Gene Ther. 13, 321-329 (2006).
116. Koeberl, D. D. et al. Early, sustained efficacy of adeno-associated virus vector-mediated gene therapy in glycogen storage disease type Ia. Gene Ther. 13, 1281-1289 (2006).
117. Koeberl, D. D. et al. AAV vector-mediated reversal of hypoglycemia in canine and murine glycogen storage disease type Ia. Mol. Ther. 16, 665-672 (2008).
118. Yiu, W. H. et al. Complete normalization of hepatic G6PC deficiency in murine glycogen storage disease type Ia using gene therapy. Mol. Ther. 18, 1076-1084 (2010).
119. Wu, Z., Miller, E., Agbandje-McKenna, M. & Samulski, R. J. Alpha2, 3 and alpha2, 6 N-linked sialic acids facilitate efficient binding and transduction by adeno-associated virus types 1 and 6. J. Virol. 80, 9093-9103 (2006).
120. Akache, B. et al. The 37/67-kilodalton laminin receptor is a receptor for adeno-associated virus serotypes 8, 2, 3, and 9. J. Virol. 80, 9831-9836 (2006).
121. Yiu, W. H., Pan, C.-J., Allamarvdasht, M., Kim, S. Y. & Chou, J. Y. Glucose-6-phosphate transporter gene therapy corrects metabolic and myeloid abnormalities in glycogen storage disease type Ib mice. Gene Ther. 14, 219-226 (2007).
122. Yiu, W. H. et al. Normoglycemia alone is insufficient to prevent long-term complications of hepatocellular adenoma in glycogen storage disease type Ib mice. J. Hepatol. 51, 909-917 (2009).